Covered recipient · General Payments record
ALIREZA SHAMS
Allopathic & Osteopathic Physicians General Practice
General Payments · PY2020–2023
$1,570.59
- Reported across 92 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $301.24 | 16 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $155.39 | 8 |
| Lilly USA, LLC | $60.49 | 4 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $41.09 | 2 |
| ABBVIE INC. | $23.66 | 1 |
| PFIZER INC. | $20.61 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AbbVie Inc. | $23.66 | 06/26/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998944121 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $20.46 | 06/05/2023 | Food and Beverage | Undisputed | 01/23/2026 | 996412951 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $20.63 | 10/16/2023 | Food and Beverage | Undisputed | 01/23/2026 | 996412947 | CMS |
| Lilly USA, LLC | $15.56 | 03/06/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1031241845 | CMS |
| Lilly USA, LLC | $14.51 | 04/03/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1031250103 | CMS |
| Lilly USA, LLC | $15.42 | 08/07/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1031225427 | CMS |
| Lilly USA, LLC | $15.00 | 09/12/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1031242881 | CMS |
| Novo Nordisk Inc | $20.00 | 05/08/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002453107 | CMS |
| Novo Nordisk Inc | $20.02 | 05/23/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002453121 | CMS |
| Novo Nordisk Inc | $5.02 | 06/01/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002453083 | CMS |
| Novo Nordisk Inc | $21.97 | 06/21/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002453133 | CMS |
| Novo Nordisk Inc | $19.03 | 08/03/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002453095 | CMS |
| Novo Nordisk Inc | $22.68 | 08/29/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002453155 | CMS |
| Novo Nordisk Inc | $24.43 | 09/07/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002453167 | CMS |
| Novo Nordisk Inc | $22.24 | 10/12/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002453143 | CMS |
| PFIZER INC. | $20.61 | 07/07/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1049589423 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2020, 2021, 2022, 2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.